Загрузка страницы

What is MicroRNA? | Ask a Prostate Expert, Mark Scholz, MD

PCRI's CEO, Alex Scholz, asks Executive Director, Mark Scholz, MD, about microRNA and how it can be used to predict side effects of radiation therapy and immunotherapy.

Don’t know your prostate cancer stage? Take the quiz: Visit http://www.prostatecancerstaging.org
To learn more about prostate cancer visit http://www.pcri.org
To download the free Staging Guide visit https://pcri.org/prostate-cancer-staging

Who we are:

The Prostate Cancer Research Institute (PCRI) is a 501(c)(3) not-for-profit organization that is dedicated to helping you research your treatment options. We understand that you have many questions, and we can help you find the answers that are specific to your case. All of our resources are designed by a multidisciplinary team of advocates and expert physicians, for patients. We believe that by educating yourself about the disease, you will have more productive interactions with your medical professionals and receive better individualized care. Feel free to explore our website or call our free helpline at 1 (800) 641-7274 with any questions that you have. Our Federal Tax ID # is 95-4617875 and qualifies for maximum charitable gift deductions by individual donors.

The information on the Prostate Cancer Research Institute's YouTube channel is provided with the understanding that the Institute is not engaged in rendering medical advice or recommendation. The information provided in these videos should not replace consultations with qualified health care professionals to meet your individual medical needs.

#ProstateCancer #Prostate #MarkScholzMD

Видео What is MicroRNA? | Ask a Prostate Expert, Mark Scholz, MD канала Prostate Cancer Research Institute
Показать
Комментарии отсутствуют
Введите заголовок:

Введите адрес ссылки:

Введите адрес видео с YouTube:

Зарегистрируйтесь или войдите с
Информация о видео
4 мая 2020 г. 23:03:16
00:03:52
Другие видео канала
Tracking Recurrent Cancer | Ask a Prostate Expert, Mark Scholz, MDTracking Recurrent Cancer | Ask a Prostate Expert, Mark Scholz, MDDoes Your Prostate Size Matter? | Mark Moyad, MD MPH & Mark Scholz, MD at the PCRI Conference 2019Does Your Prostate Size Matter? | Mark Moyad, MD MPH & Mark Scholz, MD at the PCRI Conference 2019Clinical Trial: SBRT vs IMRT For Low Risk to Intermediate-Risk Prostate Cancer | PCRIClinical Trial: SBRT vs IMRT For Low Risk to Intermediate-Risk Prostate Cancer | PCRIHIFU is FDA Approved, but Should You Get It? We ask Prostate Expert, Mark Scholz, MDHIFU is FDA Approved, but Should You Get It? We ask Prostate Expert, Mark Scholz, MDCasodex, SpaceOar, and Biopsy Reports | Ask a Prostate ExpertCasodex, SpaceOar, and Biopsy Reports | Ask a Prostate ExpertWhy Doctors Don't Talk About Brachytherapy | Ask a Prostate Expert, Mark Scholz, MDWhy Doctors Don't Talk About Brachytherapy | Ask a Prostate Expert, Mark Scholz, MDIs HDR Brachytherapy An Outdated Treatment? | Ask a Prostate Expert, Jeffrey Demanes, MDIs HDR Brachytherapy An Outdated Treatment? | Ask a Prostate Expert, Jeffrey Demanes, MDHow PSMA Can Change Treatment  Decisions for Prostate Cancer | Mark Moyad, MD, MPH & Mark Scholz, MDHow PSMA Can Change Treatment Decisions for Prostate Cancer | Mark Moyad, MD, MPH & Mark Scholz, MDChoosing Supplements For Prostate Cancer: Part TwoChoosing Supplements For Prostate Cancer: Part TwoThe Importance of Exercise While Managing Prostate Cancer | Mark Moyad, MD & Mark Scholz, MD | PCRIThe Importance of Exercise While Managing Prostate Cancer | Mark Moyad, MD & Mark Scholz, MD | PCRIOlaparib + Zytiga for Metastatic Castrate-Resistant Prostate Cancer | Learn About Clinical TrialsOlaparib + Zytiga for Metastatic Castrate-Resistant Prostate Cancer | Learn About Clinical TrialsWhat is the Best Hormone Therapy for Prostate Cancer?What is the Best Hormone Therapy for Prostate Cancer?How do You Treat Oligometastatic Prostate Cancer and What Does Cure Mean? | Ask a Prostate ExpertHow do You Treat Oligometastatic Prostate Cancer and What Does Cure Mean? | Ask a Prostate ExpertHormone Therapy & Radiation for Prostate Cancer | We Answer Your Youtube Questions #6 | The PCRIHormone Therapy & Radiation for Prostate Cancer | We Answer Your Youtube Questions #6 | The PCRIRadiation Centers, Secondary Cancers, IMRT vs Brachytherapy | Ask a Prostate Expert, Mark Scholz, MDRadiation Centers, Secondary Cancers, IMRT vs Brachytherapy | Ask a Prostate Expert, Mark Scholz, MDHormone Therapy for Intermediate-Risk (Teal) Prostate Cancer | Prostate Cancer Staging GuideHormone Therapy for Intermediate-Risk (Teal) Prostate Cancer | Prostate Cancer Staging GuideHow Avodart and Proscar Affect Libido | Mark Moyad, MD, MPH & Mark Scholz, MD | PCRIHow Avodart and Proscar Affect Libido | Mark Moyad, MD, MPH & Mark Scholz, MD | PCRIImmune, Hormone, & Radiation Combined for Prostate Cancer | Ask a Prostate Expert, Mark Scholz, MDImmune, Hormone, & Radiation Combined for Prostate Cancer | Ask a Prostate Expert, Mark Scholz, MDPSA Recurrence: When Should You Treat? | Ask a Prostate Expert, Mark Scholz, MDPSA Recurrence: When Should You Treat? | Ask a Prostate Expert, Mark Scholz, MDGene Silencing by microRNAsGene Silencing by microRNAs
Яндекс.Метрика